Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of P/D with Heated Cisplatin and Adjuvant ALIMTA/Cisplatin in Mesothelioma
NCT00165503Phase 2Terminated
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Apr 2004
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in malignant pleural mesothelioma (MPM), sponsored by Dana-Farber Cancer Institute. Started Apr 2004; status: terminated.
02
Drugs
pemetrexedcisplatin
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00165503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165503.